Chronic myelomonocytic leukemia (CMML) symptoms include fatigue, unintended weight loss, easy bleeding, and an enlarged spleen. CMML is a rare cancer that begins in the blood-forming cells in the bone ...

In the other patient with PMF, a marked reduction in a massively enlarged spleen and disappearance of pressure symptoms was also observed within the first month of treatment with IFN-2c.

In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in ...

In a remarkable scientific breakthrough, researchers have transformed a historically deadly fungus into a potential weapon in the fight against leukemia, a cancer that kills 23,670 ...

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that largely affects older adults. Discover the causes, risk factors, how it’s classified, and more information like on ...

Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL).

B-cell chronic lymphocytic leukemia (CLL) is the most common leukemia in the UK with an incidence of three cases per 100,000 individuals, equating to approximately 2000 newly diagnosed cases each ...

Wierda WG, Rawstron A, Cymbalista F, et al. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations. Leukemia. 2021;35 (11):3059-3072. doi:10.1038 ...

The clinical manifestations of MF include an enlarged spleen, debilitating symptoms and reduction in hemoglobin and/or platelets. MF affects 1 in 500,000 people worldwide. 1 ...

Anemia from beta thalassemia may require your spleen to work harder than usual to produce red blood cells. As a result, it may not be able to filter your blood as well as it did before.

AstraZeneca has secured a key approval for its BTK inhibitor Calquence in Europe, which the company has said could be a blockbuster new indication for the drug. The European Commission has cleared ...